Dementia is one of the fastest emerging global public health concerns today, as the World Health Organisation has predicted that the number of cases will triple from 55 million in 2023 to 152 million by 2050. Current evidence indicates that approximately 45% of dementia cases can be prevented or delayed by acting on potentially modifiable risk factors. However, public knowledge regarding this remains unknown in numerous poorly resourced countries, including Nepal, where the prevalence of dementia continues to increase. The lack of availability of dementia knowledge or risk-measuring tools in the native language may be accountable for this identified gap. Thus, our study aimed to translate and culturally adopt two significant measuring tools, KoDeRR, which measures the Knowledge of Dementia Risk Reduction and the DRP, which generates a Dementia Risk Profile focusing on 9 modifiable risk factors identified by WHO. KoDeRR and DRP have been translated and adapted into Nepali following the TRAPD protocol. Cognitive interviews were then conducted with five bilingual individuals to pre-test KoDeRR and DRP for cultural appropriateness, face validity, and appropriateness of language usage. Certain terms, including dementia, do not exist in Nepali, and some English words do not have direct translation. Similarly, some English words must be translated into multiple Nepali words to suit audiences from different literacy levels and various regions of Nepal. It is essential to be mindful of the choice of words used in the tools since intergenerational language disparities exist in Nepali-speaking communities, and the cultural appropriateness of the language used can vary from one language to another. Translating and adapting dementia survey tools into non-English languages is challenging and time-consuming. Despite these challenges, translating and adapting measuring tools such as KoDeRR and DRP in non-English languages will facilitate researchers' understanding of risk reduction knowledge and the risk profile of diverse communities.

Download full-text PDF

Source
http://dx.doi.org/10.1177/14713012251315329DOI Listing

Publication Analysis

Top Keywords

dementia risk
16
risk profile
12
risk reduction
12
measuring tools
12
koderr drp
12
dementia
10
risk
8
knowledge dementia
8
diverse communities
8
modifiable risk
8

Similar Publications

Dementia is one of the fastest emerging global public health concerns today, as the World Health Organisation has predicted that the number of cases will triple from 55 million in 2023 to 152 million by 2050. Current evidence indicates that approximately 45% of dementia cases can be prevented or delayed by acting on potentially modifiable risk factors. However, public knowledge regarding this remains unknown in numerous poorly resourced countries, including Nepal, where the prevalence of dementia continues to increase.

View Article and Find Full Text PDF

Modifiable risk factors and symptom progression in dementia over up to 8 years-Results of the DelpHi-MV trial.

Alzheimers Dement (Amst)

January 2025

Health Care Research Deutsches Zentrum für Neurodegenerative Erkrankungen (DZNE) Greifswald Mecklenburg-Vorpommern Germany.

Introduction: This study investigated the association between modifiable factors and symptom progression in dementia over up to 8 years.

Methods: Multilevel growth curve models assessed the role of modifiable risk factors (low education, hearing impairment and its treatment, depression, physical inactivity, diabetes and its treatment, smoking, hypertension and its treatment, obesity, alcohol consumption, social isolation, and visual impairment) on cognitive and functional trajectories in 353 people with dementia.

Results: Higher education was associated with higher initial cognitive status but faster decline.

View Article and Find Full Text PDF

Objective: Many risk factors affect dementia and all-cause mortality. However, whether falls are a risk factor for dementia and all-cause mortality is unclear. The study examines the association of falls with the risk of dementia and all-cause mortality, and whether dementia mediates the association of falls with all-cause mortality.

View Article and Find Full Text PDF

Trends in Co-morbid Dementia and Chronic Kidney Disease.

J Gen Intern Med

January 2025

Center for Chronic Disease Research and Policy, University of Chicago Medicine, Chicago, IL, USA.

Background: Little is known about the population of Medicare beneficiaries with both chronic kidney disease (CKD) and Alzheimer's disease and related dementias (ADRD).

Methods: Using data from Medicare fee-for-service (FFS) beneficiaries aged 65 and over identified through 2011-2019 Master Beneficiary Summary File (MBSF), we estimated the size, growth, and racial-ethnic characteristics of the ADRD and CKD populations. Individuals were classified as having ADRD and CKD based on CMS Chronic Conditions Data Warehouse (CCW) indicators in the MBSF Chronic Conditions file.

View Article and Find Full Text PDF

Patient reported tools for assessing potential medicine-related symptoms: A systematic review.

Res Social Adm Pharm

January 2025

Quality Use of Medicines and Pharmacy Research Centre, UniSA Clinical and Health Sciences, University of South Australia, Adelaide, 5001, Australia.

Background: Medicine-related symptom assessment tools have been developed to assist healthcare professionals in detecting potential medicine-related symptoms. This systematic review aimed to identify and evaluate the measurement properties of medicine-related symptom assessment tools.

Method: A systematic search was conducted in Ovid Medline, Ovid Embase, Ovid PsychInfo, and SCOPUS databases up to March 16, 2024.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!